Stopping GLP-1 drugs like Ozempic quickly erodes heart protection, with two years off the medication raising cardiovascular ...
People who quit taking popular GLP-1 drugs such as Ozempic might their jeopardize heart health, according to a new study.
An eye-opening study from the VA Saint Louis Healthcare System shows what quitting weight-loss drugs can do to the heart.
A new study of 333,000 patients found that stopping weight loss drugs like Ozempic reverses key health benefits.
The FDA has approved a higher 7.2 mg dose of Novo Nordisk’s Wegovy (Wegovy HD) for chronic weight management in adults with ...
The FDA approved Wegovy HD, a higher-dose semaglutide for weight loss in adults with obesity, offering greater weight ...
Low doses of the injectable weight-loss medication semaglutide may improve symptoms of a hard-to-treat type of heart failure. This effect happened through direct action on the heart muscle and blood ...
WE’RE SHINING A SPOTLIGHT ON CARDIOVASCULAR CARE. TODAY, WE’RE EXPLORING HOW WEIGHT LOSS MEDICATIONS ARE PLAYING A ROLE IN PREVENTING HEART DISEASE. JOINING ME THIS MORNING IS DOCTOR VIJAY. CASEY.
Metoprolol, acebutolol, and propranolol are heart medications linked to weight gain. Other heart medications may cause weight gain, but some might cause weight loss or be weight neutral. Many ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results